Last reviewed · How we verify

The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (Gloria)

NCT02585258 PHASE4 COMPLETED Results posted

Comparing the cost-effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis: The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (GLORIA)

Details

Lead sponsorAmsterdam UMC, location VUmc
PhasePHASE4
StatusCOMPLETED
Enrolment451
Start dateThu Jun 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionThu Dec 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Italy, Netherlands, Slovakia, Germany, Hungary, Romania, Portugal